Further, pharmaceutical inhibition of SKP2 E3 ligase activity using SZL P1‐41 in C4‐2B and 22Rv1 nude mice impaired SKP2–FOXA1 interactions subsequently reducing tumor proliferation. Here, SKP2 is linked to neoplasm.